Highly drug/target-tolerant neutralizing antibody (NAb) assay development through target-based drug depletion and drug-based NAb extraction for an anti-EGFR therapeutic monoclonal antibody
Article in Journal of Pharmaceutical and Biomedical Analysis (February 2024)